{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:51:28Z","timestamp":1785174688433,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1245\/s10434-025-17648-4","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:40:14Z","timestamp":1750149614000},"page":"6303-6311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor Radioactivity in 99mTc-GSA Scintigraphy Predicts Oncological Outcomes in Patients Who Underwent Hepatectomy for Hepatocellular Carcinoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Kenei","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Gomisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Onda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tsunematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"17648_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"17648_CR2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/hepr.13771","volume":"52","author":"K Maesaka","year":"2022","unstructured":"Maesaka K, Sakamori R, Yamada R, et al. Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma. Hepatol Res. 2022;52:630\u201340.","journal-title":"Hepatol Res"},{"key":"17648_CR3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20132.","journal-title":"Hepatology"},{"key":"17648_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-200007000-00003","volume":"232","author":"R Tung-Ping Poon","year":"2000","unstructured":"Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10\u201324.","journal-title":"Ann Surg"},{"key":"17648_CR5","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1245\/s10434-023-13228-6","volume":"30","author":"J Shindoh","year":"2023","unstructured":"Shindoh J, Matsumura M, Kobayashi M, Akabane M, Okubo S, Hashimoto M. Disease-free interval and tumor stage complementarily predict the biological behavior of recurrent hepatocellular carcinoma. Ann Surg Oncol. 2023;30:3402\u201310.","journal-title":"Ann Surg Oncol"},{"key":"17648_CR6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jhep.2012.07.018","volume":"57","author":"H Toyoda","year":"2012","unstructured":"Toyoda H, Kumada T, Tada T, et al. Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy. J Hepatol. 2012;57:1251\u20132127.","journal-title":"J Hepatol"},{"key":"17648_CR7","doi-asserted-by":"crossref","first-page":"e2133","DOI":"10.1097\/MD.0000000000002133","volume":"94","author":"MX Li","year":"2015","unstructured":"Li MX, Bi XY, Li ZY, et al. Prognostic role of Glasgow prognostic Score in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e2133.","journal-title":"Medicine (Baltimore)"},{"key":"17648_CR8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1245\/s10434-016-5713-2","volume":"24","author":"J Zheng","year":"2017","unstructured":"Zheng J, Kuk D, G\u00f6nen M, et al. Actual 10-year survivors after resection of hepatocellular carcinoma. Ann Surg Oncol. 2017;24:1358\u201366.","journal-title":"Ann Surg Oncol"},{"key":"17648_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/9780470122860.ch3","volume":"41","author":"G Ashwell","year":"1974","unstructured":"Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol. 1974;41:99\u2013128.","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"17648_CR10","first-page":"32","volume":"40","author":"Y Kubota","year":"1993","unstructured":"Kubota Y, Kitagawa S, Inoue K, Ha-Kawa SK, Kojima M, Tanaka Y. Hepatic functional scintigraphic imaging with 99mtechnetium galactosyl serum albumin. Hepatogastroenterology. 1993;40:32\u20136.","journal-title":"Hepatogastroenterology"},{"key":"17648_CR11","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-21-4337","volume":"82","author":"X Zhu","year":"2022","unstructured":"Zhu X, Song G, Zhang S, et al. asialoglycoprotein receptor 1 functions as a tumor suppressor in liver cancer via inhibition of STAT3. Cancer Res. 2022;82:3987\u20134000.","journal-title":"Cancer Res"},{"key":"17648_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/hepr.13411","volume":"49","author":"N Kokudo","year":"2019","unstructured":"Kokudo N, Takemura N, Hasegawa K, et al. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019;49:1109\u201313.","journal-title":"Hepatol Res"},{"key":"17648_CR13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-9610(99)80227-X","volume":"169","author":"S Miyagawa","year":"1995","unstructured":"Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589\u201394.","journal-title":"Am J Surg"},{"key":"17648_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1159\/000439101","volume":"33","author":"M Kudo","year":"2015","unstructured":"Kudo M, Kitano M, Sakurai T, Nishida N. general rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the Liver Cancer Study Group of Japan. Dig Dis. 2015;33:765\u201370.","journal-title":"Dig Dis"},{"key":"17648_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"17648_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0928-4346(96)00325-8","volume":"6","author":"F Ichida","year":"1996","unstructured":"Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6:112\u20139.","journal-title":"Int Hepatol Commun"},{"key":"17648_CR17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ags3.12804","volume":"8","author":"M Akaoka","year":"2024","unstructured":"Akaoka M, Haruki K, Yamahata Y, et al. The prognostic impact of perioperative dynamic changes in cachexia index in patients with hepatocellular carcinoma. Ann Gastroenterol Surg. 2024;8:917\u201326.","journal-title":"Ann Gastroenterol Surg"},{"key":"17648_CR18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/hepr.12599","volume":"46","author":"D Witzigmann","year":"2016","unstructured":"Witzigmann D, Quagliata L, Schenk SH, Quintavalle C, Terracciano LM, Huwyler J. Variable asialoglycoprotein receptor 1 expression in liver disease: implications for therapeutic intervention. Hepatol Res. 2016;46:686\u201396.","journal-title":"Hepatol Res"},{"key":"17648_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00705-010-0903-x","volume":"156","author":"X Zhang","year":"2011","unstructured":"Zhang X, Lin SM, Chen TY, et al. Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro. Arch Virol. 2011;156:637\u201345.","journal-title":"Arch Virol"},{"key":"17648_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000335713","volume":"29","author":"A Guglielmi","year":"2012","unstructured":"Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg. 2012;29:6\u201317.","journal-title":"Dig Surg"},{"key":"17648_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12893-024-02624-8","volume":"24","author":"S Mii","year":"2024","unstructured":"Mii S, Takahara T, Shibasaki S, et al. 99mTc-GSA scintigraphy and modified albumin-bilirubin score can be complementary to ICG for predicting posthepatectomy liver failure. BMC Surg. 2024;24:342.","journal-title":"BMC Surg"},{"key":"17648_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00534-010-0264-6","volume":"17","author":"Y Iimuro","year":"2010","unstructured":"Iimuro Y, Kashiwagi T, Yamanaka J, et al. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT\/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci. 2010;17:673\u201381.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"17648_CR23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11307-017-1046-1","volume":"19","author":"R Haubner","year":"2017","unstructured":"Haubner R, Schmid AM, Maurer A, et al. [(68)Ga]NOTA-galactosyl human serum albumin: a tracer for liver function imaging with improved stability. Mol Imaging Biol. 2017;19:723\u201330.","journal-title":"Mol Imaging Biol"},{"key":"17648_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41181-024-00271-1","volume":"9","author":"MA Zierke","year":"2024","unstructured":"Zierke MA, Rangger C, Samadikhah K, et al. [68Ga]Ga-NODAGA-TriGalactan, a low molecular weight tracer for the non-invasive imaging of the functional liver reserve. EJNMMI Radiopharm Chem. 2024;9:41.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"17648_CR25","doi-asserted-by":"crossref","first-page":"116278","DOI":"10.1016\/j.ejmech.2024.116278","volume":"269","author":"Y Hua","year":"2024","unstructured":"Hua Y, Yu C. Research progress on asialoglycoprotein receptor-targeted radiotracers designed for hepatic nuclear medicine imaging. Eur J Med Chem. 2024;269:116278.","journal-title":"Eur J Med Chem"},{"key":"17648_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000726","author":"A Vogel","year":"2023","unstructured":"Vogel A, Grant RC, Meyer T, Sapisochin G, O\u2019Kane GM, Saborowski A. Adjuvant and neoadjuvant therapies for hepatocellular carcinoma. Hepatology. 2023. https:\/\/doi.org\/10.1097\/HEP.0000000000000726.","journal-title":"Hepatology"},{"key":"17648_CR27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/XCS.0000000000001032","volume":"238","author":"K Haruki","year":"2024","unstructured":"Haruki K, Harimoto N, Furukawa K, et al. Proposal for prognosis-oriented definition of borderline resectable hepatocellular carcinoma. J Am Coll Surg. 2024;238:1137\u201347.","journal-title":"J Am Coll Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17648-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:01:41Z","timestamp":1754150501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17648-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["17648"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17648-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no commercial interests to disclosure.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}